Journal Highlight : Cancer Pharmacology and Therapeutic Development
The journal welcomes scholarly contributions related to the pharmacological principles, therapeutic strategies, and clinical applications of anticancer agents in oncology research and practice. This section focuses on research that advances the understanding of cancer pharmacology, improves therapeutic efficacy and safety, and supports the development of innovative treatment approaches for cancer management.
The journal encourages submissions in areas including Cancer Pharmacology, Anticancer Drug Development, Chemotherapy, Targeted Cancer Therapy, Immunotherapeutics, Pharmacokinetics and Pharmacodynamics, Precision Oncology Therapeutics, Combination Therapy Strategies, Hormonal Cancer Therapy, and Experimental Cancer Therapeutics. Research related to Drug Mechanisms of Action, Therapeutic Resistance, Cancer Drug Toxicity, Pharmacogenomics, Nanotechnology-Based Drug Delivery, Biological and Biosimilar Therapies, and Translational Therapeutic Development is also welcomed.
Submissions focusing on Clinical Trials in Oncology Therapeutics, Personalized Cancer Treatment, Biomarker-Guided Therapy, Therapeutic Response Monitoring, Optimization of Anticancer Regimens, Supportive and Adjunctive Cancer Therapies, Drug Repurposing in Oncology, and AI and Computational Approaches in Cancer Therapeutics are encouraged. The journal also welcomes studies investigating novel therapeutic targets, treatment safety, adverse event management, and long-term outcomes associated with anticancer therapies.
Accepted manuscript types include Original Research Articles, Systematic Reviews, Meta-Analyses, Experimental and Preclinical Studies, Clinical Studies, Translational Research Articles, Clinical Trial Reports, and Technology and Methodology Articles that contribute to advancements in cancer pharmacology and oncology therapeutics.
Through this focus area, the journal aims to support research that advances anticancer drug development, improves therapeutic precision and patient safety, enhances personalized oncology care, and contributes to innovative and evidence-based cancer treatment strategies worldwide.
